Next Article in Journal
Characterization of a Single Chain Fv Antibody that Reacts with Free Morphine
Next Article in Special Issue
Selective Induction of Cancer Cell Death by Targeted Granzyme B
Previous Article in Journal
Shark Variable New Antigen Receptor (VNAR) Single Domain Antibody Fragments: Stability and Diagnostic Applications
Previous Article in Special Issue
Dissecting the Entry Route of Saporin-based a-CD7 Immunotoxins in Human T-Cell Acute Lymphoblastic Leukaemia Cells
Article Menu

Export Article

Open AccessReview
Antibodies 2013, 2(1), 82-92; doi:10.3390/antib2010082

An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells

1
Department of Pharmacology, University of Minnesota, 210 Delaware Street Southeast Minneapolis, MN 55455, USA
2
Department of Therapeutic Radiology-Radiation Oncology, Section on Molecular Cancer Therapeutics, University of Minnesota Masonic Cancer Center, 425 East River Parkway Minneapolis, MN 55455, USA
*
Author to whom correspondence should be addressed.
Received: 6 December 2012 / Revised: 19 January 2013 / Accepted: 22 January 2013 / Published: 28 January 2013
(This article belongs to the Special Issue Recombinant Immunotoxins)
View Full-Text   |   Download PDF [169 KB, uploaded 28 January 2013]

Abstract

Targeting and killing specific cells discriminately has been the goal of targeted therapy dating back to the era of Paul Ehrlich. The discovery of cancer stem cells has caused a paradigm shift within the cancer field and provided an opportunity to use targeted therapies such as targeted toxins to bind and kill these cells selectively. A number of targeted toxins have been developed against recently identified cancer stem cell markers. In this review we discuss the development and current status of these exciting novel drugs and their potential use to combat drug-refractory relapse. View Full-Text
Keywords: cancer stem cells; targeted toxins; immunotoxins; CD133; EpCAM; CD123; CD44 cancer stem cells; targeted toxins; immunotoxins; CD133; EpCAM; CD123; CD44
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Waldron, N.N.; Vallera, D.A. An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells. Antibodies 2013, 2, 82-92.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top